Sleep Positioning Systems for Children and Adultswith a Neurodisability a Systematic Review

Review

. 2015;2015(11):CD009257.

doi: 10.1002/14651858.CD009257.pub2. Epub 2015 Nov 2.

Sleep positioning systems for children with cerebral palsy

Affiliations

• PMID: 26524348
• PMCID: PMC8761500
• DOI: 10.1002/14651858.CD009257.pub2

Free PMC article

Review

Sleep positioning systems for children with cerebral palsy

Sharon F Blake  et al. Cochrane Database Syst Rev. 2015 .

Free PMC article

Abstract

Background: Sleep positioning systems can be prescribed for children with cerebral palsy to aid reduce or foreclose hip migration, provide comfort to ease pain and/or improve sleep. Every bit sleep disturbance is common in children with developmental disabilities, with impact on their carers' slumber, and as sleep positioning systems tin exist expensive, guidance is needed to support decisions as to their use.

Objectives: To make up one's mind whether commercially-available sleep positioning systems, compared with usual care, reduce or foreclose hip migration in children with cognitive palsy. Whatsoever negative effect of slumber positioning systems on hip migration will be considered within this objective.Secondary objectives were to determine the effect of sleep positioning systems on: (1) number or frequency of hip bug; (2) slumber patterns and quality; (3) quality of life of the kid and family unit; (4) pain; and (5) physical functioning. We as well sought to identify whatever adverse furnishings from using sleep positioning systems.

Search methods: In December 2014, nosotros searched Cardinal, Ovid MEDLINE, Embase, and xiii other databases. We likewise searched ii trials registers. We practical no restrictions on date of publication, language, publication status or study blueprint. Nosotros checked references and contacted manufacturers and authors for potentially relevant literature, and searched the net using Google.

Selection criteria: We included all randomised controlled trials (RCTs) evaluating whole body slumber positioning systems for children and adolescents (up to 18 years of age) with cognitive palsy.

Data collection and analysis: Ii review authors independently screened reports retrieved from the search against pre-adamant inclusion criteria and assessed the quality of eligible studies.Members of the public (parent carers of children with neurodisability) contributed to this review by suggesting the topic, refining the enquiry objectives, interpreting the findings, and reviewing the plain language summary.

Main results: We did not identify any randomised controlled trials that evaluated the effectiveness of sleep positioning systems on hip migration.We did discover two randomised cross-over trials that met the inclusion criteria in respect of secondary objectives relating to sleep quality and pain. Neither report reported any important difference between sleeping in slumber positioning systems and not for slumber patterns or slumber quality (two studies, 21 children, very low quality evidence) and pain (one study, eleven children, very low quality prove). These were small studies with established users of sleep positioning systems and were judged to have high risk of bias.We institute no eligible trials that explored the other secondary objectives (number or frequency of hip problems, quality of life of the child and family, concrete performance, and adverse effects).

Authors' conclusions: We found no randomised trials that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip migration in children with cerebral palsy. Nor did nosotros find any randomised trials that evaluated the issue of slumber positioning systems on the number or frequency of hip problems, quality of life of the child and family or on physical performance.Limited data from 2 randomised trials, which evaluated the effectiveness of sleep positioning systems on sleep quality and pain for children with cerebral palsy, showed no pregnant differences in these aspects of health when children were using and not using a sleep positioning organization.In order to inform clinical decision-making and the prescription of sleep positioning systems, more rigorous research is needed to determine effectiveness, cost-effectiveness, and the likelihood of adverse effects.

Disharmonize of interest statement

This review benefited from support from National Institute for Wellness Enquiry (NIHR) Collaboration for Leadership in Practical Health Research and Care of the South West Peninsula (PenCLAHRC) and the charity Cerebra. They had no influence on the comport or reporting of the work. The views and opinions expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Wellness, or Cerebra.

Stuart Logan, Ginny Humphreys, Morwenna Rogers, Joanna Thompson‐Coon, Katrina Wyatt and Christopher Morris are or have been principal or co‐investigators on NIHR grants and/or grants from other funding agencies unrelated to this review, unless otherwise declared.

Sharon F Blake‐ none known. Stuart Logan ‐ none known. Ginny Humphreys is the author of an excluded written report Humphreys 2012. She has non been involved in the assessment of eligibility, take chances of bias, and data extraction for this review. Ginny Humphreys and Christopher Morris are co‐investigators for a pilot randomised controlled trial (RCT) evaluating sleep positioning systems for the aforementioned population UKCRN ID 10914 which is an ongoing study. Two independent authors, Sharon Blake and Morwenna Rogers, assessed the eligibility of this study and found that it would come across the criteria for inclusion. No data were available at the fourth dimension of writing. When data become available, the writer team will ensure that the 'Risk of bias' cess and data extraction volition be carried out past independent authors who accept not been involved in this study. Justin Matthews ‐ none known. Morwenna Rogers ‐ none known. Joanna Thompson‐Coon ‐ none known. Katrina Wyatt ‐ none known. Christopher Morris declares that none of his alleged potential conflicts of interest have knowingly biased the piece of work he has done on this Cochrane review.

Figures

1

Study flow diagram

ii

Run a risk of bias summary: Review authors' judgements about each adventure of bias item for each included study.

Update of

• doi: 10.1002/14651858.CD009257

Similar articles

• Do interventions for cerebral palsy.

  Ryan JM, Cassidy EE, Noorduyn SG, O'Connell NE. Ryan JM, et al. Cochrane Database Syst Rev. 2017 Jun 11;vi(6):CD011660. doi: ten.1002/14651858.CD011660.pub2. Cochrane Database Syst Rev. 2017. PMID: 28602046 Free PMC article. Review.

• Intrathecal baclofen for treating spasticity in children with cerebral palsy.

  Hasnat MJ, Rice JE. Hasnat MJ, et al. Cochrane Database Syst Rev. 2015 November xiii;(11):CD004552. doi: x.1002/14651858.CD004552.pub2. Cochrane Database Syst Rev. 2015. PMID: 26563961 Review.

• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

  Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog Yard, Holmskov Thousand, Rosendal South, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen 1000, Gauci D, Zwi One thousand, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C. Storebø OJ, et al. Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. PMID: 26599576 Free PMC article. Review.

• Bisphosphonate use in children with cerebral palsy.

  Hurley T, Zareen Z, Stewart P, McDonnell C, McDonald D, Molloy E. Hurley T, et al. Cochrane Database Syst Rev. 2021 Jul 5;vii(vii):CD012756. doi: 10.1002/14651858.CD012756.pub2. Cochrane Database Syst Rev. 2021. PMID: 34224134

• Peer support interventions for parents and carers of children with complex needs.

  Sartore GM, Pourliakas A, Lagioia V. Sartore GM, et al. Cochrane Database Syst Rev. 2021 December 20;12(12):CD010618. doi: x.1002/14651858.CD010618.pub2. Cochrane Database Syst Rev. 2021. PMID: 34923624 Review.

Cited by 2 articles

• [Otorhinolaryngological diseases in pregnancy-which drugs are approved?].

  Paulus Nosotros, Lindemann J, Friebe-Hoffmann U. Paulus WE, et al. HNO. 2022 Mar;70(3):239-248. doi: 10.1007/s00106-021-01144-8. Epub 2022 Jan 24. HNO. 2022. PMID: 35075518 German language.

• State of the Testify Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy.

  Novak I, Morgan C, Fahey 1000, Finch-Edmondson Thousand, Galea C, Hines A, Langdon K, Namara MM, Paton MC, Popat H, Shore B, Khamis A, Stanton E, Finemore OP, Tricks A, Te Velde A, Dark L, Morton N, Badawi N. Novak I, et al. Curr Neurol Neurosci Rep. 2020 Feb 21;twenty(2):3. doi: 10.1007/s11910-020-1022-z. Curr Neurol Neurosci Rep. 2020. PMID: 32086598 Gratis PMC article.

Publication types

MeSH terms

LinkOut - more resource

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley

• Medical

  • Genetic Alliance
  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Data

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal

aguilarwastoponcen.blogspot.com

Source: https://pubmed.ncbi.nlm.nih.gov/26524348/

Share this post